6DECEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIf there is one concern that has confounded the population of 2020, it is vaccine discovery and development to curb the coronavirus. And it is a situation like this that highlights the intricacies behind developing a vaccine. In essence, to keep up with the ever-changing panorama of microbes and diseases, pharmaceutical organisations are planning to incorporate the latest technologies that can help them accelerate their operations and devise vaccines in the shortest period of time. In the near future, the latest technologies like genetic engineering will boost the pharma industry a long way, fuelling rapid advances in vaccine technology. Besides, the rise in vaccine targets, combined with effective formulations, adjuvants, and routes of delivery, will also necessitate the need for new solutions that can simplify these processes and reduce the economic burden for the stakeholders. Considering all such technological trends entering the sector, organisations will have to equip themselves with the latest vaccine discovery and development solutions to meet the evolving requirements.When all things are considered, there is no doubt that the businesssector is on the fast track of evolution. Standing at the cusp of vaccine discovery and development technology, there are a wide range of solution providerswhich offer the latest technologies best suited for the next generation of vaccine and drug development needs. To help clients steer through the best-of-breed companies, Pharma Tech Outlook has compiled a list of top 10vaccine discovery and development solution providers in Europe.These organisations are transforming the sales and marketing landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the vaccine discovery and development space on the latest industry trends, best practices, recent innovations, and highlights their expertise. Let us know your thoughts!Genetic Engineering to Lead the Way in Vaccine DevelopmentCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 29 - 2020, Vol 06 - Issue 35 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Jaxon JaseTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >